Matthew Ronsheim's Net Worth
$673 Thousand
Who is Matthew Ronsheim?
Matthew Ronsheim does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Entasis Therapeutics Holdings Inc., and Innoviva, Inc..
SEC CIK
Matthew Ronsheim's CIK is 0001824386
Past Insider Trading and Trends
2021 was Matthew Ronsheim's most active year for acquiring shares with 3 total transactions. Matthew Ronsheim's most active month to acquire stocks was the month of December. 2022 was Matthew Ronsheim's most active year for disposing of shares, totalling 6 transactions. Matthew Ronsheim's most active month to dispose stocks was the month of June. 2024 saw Matthew Ronsheim paying a total of $189,987.84 for 100,106 shares, this is the most they've acquired in one year. In 2022 Matthew Ronsheim cashed out on 255,905 shares for a total of $38,658.40, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Entasis Therapeutics Holdings Inc. No price found
Chief Pharma Sciences & MFGMatthew Ronsheim used to own units in Common Stock but no longer holds any shares there. In the year 2020 Matthew Ronsheim acquired a total of 175,000 shares in Entasis Therapeutics Holdings Inc., Matthew also disposed a total of 175,000 shares of Entasis Therapeutics Holdings Inc. equalling to $61,436.47.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -167.57K |
$2.20 | -$38,658.40 |
0
|
Jul 7 - Jul 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 16
| |||
Form 4
| +293.62% | 125K |
—
|
—
| 167.57K |
Jan 18
| |||
Form 4
| -7.93% | -3.67K |
$2.94 | -$10,786.86 | 42.57K |
Nov 2
| |||
Form 4
| +84.96% | 21.24K |
$3.19 | -$11,991.21 | 46.24K |
Oct 19
| |||
Form 4
|
∞
| 25K |
—
|
—
| 25K |
Jan 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Innoviva, Inc. (INVA) Snapshot price: $18.7201
See RemarksMatthew Ronsheim owns 40,510 units of Common Stock which is worth $758,351.25. In the year 2024 Matthew Ronsheim filed a total of 5 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.66% | -268.00 |
$16.13 | -$4,322.84 | 40.51K |
May 20
| |||
Form 4
| +45.58% | 12.77K |
$14.88 | $189,987.84 | 40.78K |
Mar 5
| |||
Form 4
| -2.80% | -807.00 |
$15.80 | -$12,750.60 | 28.01K |
Feb 20
| |||
Form 4
| -5.26% | -1.60K |
$16.05 | -$25,680.00 | 28.82K |
Jan 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||